The changing epidemiology of human monkeypox—A potential threat? A systematic review

Summary

Monkeypox, a zoonotic disease caused by an orthopoxvirus, results in a smallpox-like disease in humans. Since monkeypox in humans was initially diagnosed in 1970 in the Democratic Republic of the Congo (DRC), it has spread to other regions of Africa (primarily West and Central), and cases outside Africa have emerged in recent years. We conducted a systematic review of peer-reviewed and grey literature on how monkeypox epidemiology has evolved, with particular emphasis on the number of confirmed, probable, and/or possible cases, age at presentation, mortality, and geographical spread. The review is registered with PROSPERO (CRD42020208269). We identified 48 peer-reviewed articles and 18 grey literature sources for data extraction. The number of human monkeypox cases has been on the rise since the 1970s, with the most dramatic increases occurring in the DRC. The median age at presentation has increased from 4 (1970s) to 21 years (2010–2019). There was an overall case fatality rate of 8.7%, with a significant difference between clades—Central African 10.6% (95% CI: 8.4%– 13.3%) vs. West African 3.6% (95% CI: 1.7%– 6.8%). Since 2003, import- and travel-related spread outside of Africa has occasionally resulted in outbreaks. Interactions/activities with infected animals or individuals are risk behaviors associated with acquiring monkeypox. Our review shows an escalation of monkeypox cases, especially in the highly endemic DRC, a spread to other countries, and a growing median age from young children to young adults. These findings may be related to the cessation of smallpox vaccination, which provided some cross-protection against monkeypox, leading to increased human-to-human transmission. The appearance of outbreaks beyond Africa highlights the global relevance of the disease. Increased surveillance and detection of monkeypox cases are essential tools for understanding the continuously changing epidemiology of this resurging disease.

Related articles

• Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

  This study assesses the efficacy of preoperative short-term radiotherapy followed by chemotherapy compared to standard long-term chemoradiotherapy in patients with locally advanced rectal cancer, evaluating outcomes such as disease-free survival and treatment toxicity.

• Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis

  This document discusses the adoption of the kappa free light chain (KFLC) index as a diagnostic tool for multiple sclerosis (MS), detailing its role alongside MRI and expert assessments to enhance diagnostic accuracy and reduce latency.

• Diagnostic Performance of Red Blood Cell Indices in the Differential Diagnosis of Iron Deficiency Anemia and the Thalassemia Trait in Chile: A Retrospective Study

  This retrospective study evaluates the diagnostic performance of 29 red blood cell indices in differentiating between iron deficiency anemia and the thalassemia trait in Chile, analyzing CBC results from 182 patients.

• MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR): PART II-Restaging and response evaluation

  This document presents updated consensus recommendations for the use of MRI in the restaging and response evaluation of rectal cancer after neoadjuvant treatment, developed by a panel of experts from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR).

• NURSING BULLETS FUNDAMENTALS OF NURSING

  This document serves as a comprehensive guide for nursing fundamentals, covering essential topics and clinical practices for nurses, including patient safety, medication administration, and nursing processes.